Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists, blockers |
Mechanism ADRA1 antagonists(Adrenergic receptor alpha-1 antagonists), VDCCs blockers(Voltage-gated calcium channel blockers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC38H44ClN3O12S |
InChIKeyZGIXMRGKCVFXBF-MFABWLECSA-N |
CAS Registry150284-32-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arrhythmias, Cardiac | Phase 2 | Japan | - | |
Hypertension | Phase 2 | Japan | - | |
Myocardial Infarction | Phase 2 | Japan | - |